These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 18653022)

  • 1. Regression of left ventricular hypertrophy in hypertensive elderly patients with carvedilol.
    Verza M; Ammendola S; Cambardella A; Scoti G; Vescio S; Tortoriello R; Amato L; Cerqua G; Varricchio G
    Arch Gerontol Geriatr; 1996; 22 Suppl 1():143-7. PubMed ID: 18653022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B; Petrović D; Obrenović R
    Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy in hypertension with indapamide.
    Sami M; Haichin R
    Am Heart J; 1991 Oct; 122(4 Pt 2):1215-8. PubMed ID: 1833967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
    Kartal O; Inal V; Baysan O; Sağlam K
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beneficial effects of Hartil on cardiovascular remodeling process in elderly and old patients with isolated systolic arterial hypertension].
    Kiphshidze N; Zubiashvili T; Chagunava K
    Georgian Med News; 2008 Jan; (154):7-13. PubMed ID: 18323584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension.
    Cuspidi C; Negri F; Giudici V; Valerio C; Meani S; Sala C; Esposito A; Masaidi M; Zanchetti A; Mancia G
    J Hypertens; 2009 Apr; 27(4):854-60. PubMed ID: 19516183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J; Ceypová K; Kristenová P; Hauser T
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic stiffness and distensibility among hypertensives.
    Meenakshisundaram R; Kamaraj K; Murugan S; Thirumalaikolundusubramanian P
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E68-71. PubMed ID: 19751418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the incidences of left ventricular hypertrophy, left ventricular diastolic dysfunction, and arrhythmia between patients with dipper and non-dipper hypertension].
    Ersoylu ZD; Tuğcu A; Yildirimtürk O; Aytekin V; Aytekin S
    Turk Kardiyol Dern Ars; 2008 Jul; 36(5):310-7. PubMed ID: 18984982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of rapid blood pressure control on P-wave dispersion in hypertensive urgency.
    Karaca I; Durukan P; Dagli N; Yavuzkir M; Ikizceli I; Balin M
    Adv Ther; 2008 Dec; 25(12):1303-14. PubMed ID: 19043679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy.
    Verdecchia P; Angeli F; Cavallini C; Mazzotta G; Repaci S; Pede S; Borgioni C; Gentile G; Reboldi G
    J Hypertens; 2009 Aug; 27(8):1697-704. PubMed ID: 19424088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperleptinemia--non-haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive overweight females.
    Selthofer-Relatić K; Radić R; Vizjak V; Vcev A; Kosović P; Bosnjak I; Selthofer R
    Coll Antropol; 2008 Sep; 32(3):681-5. PubMed ID: 18982737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.